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Abstract
Background: Despite the evidence-based value of cervical cancer screening, recent updates to
guidelines, and general availability of the Papanicolaou (Pap) test, guideline-adherent screening
rates remain low. The COVID-19 pandemic further impedes progress as preventive healthcare is
delayed and patients are reluctant to enter healthcare facilities. Objectives: The purpose of this
project was to evaluate if provider education and patient reminder letters comprising written
education and risk-mitigation efforts improved cervical cancer screening rates and increased
providers’ knowledge of appropriate follow-up during reopening of a metro family practice
clinic amid the COVID-19 pandemic. Methods: A multi-faceted quality improvement project
included a 3-month intervention phase comprised of: (1) provider education with descriptive
analysis of pre- and post-intervention knowledge of cervical cancer screening scores as well as,
(2) distribution of reminder letters to 295 eligible patients. Results: The overall cervical cancer
screening rate increased by 1% during the 3-month period. Provider questionnaire scores noted a
significant increase in knowledge and intent to change practice patterns (p<.05) and confirmed a
significant improvement in providers’ knowledge of cervical cancer screening and management
of abnormal cervical cytology/histology following implementation of provider education
(p<.05). Conclusion: Findings indicate that provider education improves knowledge of cervical
cancer screening and follow-up, as well as, fosters an intent to change practice patterns according
to established guidelines. Reminder letters did provide a modest increase in cervical cancer
screening rates during the COVID-19 pandemic suggesting that written education and riskmitigation efforts can encourage patients to schedule in-person appointments.
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Introduction

Human papillomavirus (HPV) is the most common sexually transmitted virus worldwide
(World Health Organization, 2014) and ordinarily presents without symptoms. There are 100
types of HPV, 14 of which can cause cancer (World Health Organization, 2014). HPV either
resolves spontaneously or remains as a persistent infection. Cervical cancer is primarily caused
by persistent infection with “high risk” HPV; therefore, cervical cancer is largely preventable by
vaccinating against HPV and by screening for precancerous lesions. Based on the woman’s age
and medical history, a cytological Papanicolaou (Pap) test and/or an HPV test are performed for
cervical cancer screening.
In cases of cervical precancer, a distinct change in the epithelial cells of the
transformation zone of the cervix is identified (World Health Organization, 2014). Precancerous
changes of the cervix are classified as cervical intraepithelial neoplasia (CIN) and are graded by
severity, from CIN1 to CIN3, with CIN3 being carcinoma in situ (Nardi et al., 2016). Cervical
precancer may last several (10-20) years before progressing to invasive cancer, thus allowing
ample opportunity for screening, detection and treatment (World Health Organization, 2014).
The incidence of cases and deaths from cervical cancer have decreased in response to effective
screening and treatment, yet cervical cancer remains one of the leading causes of cancer death in
women worldwide (World Health Organization, 2014). This statistic is especially problematic in
the wake of COVID-19, a global pandemic, which has prompted a sharp decline in preventive
care. Health systems around the world are prioritizing urgent visits and delaying elective care in
an effort to reduce COVID-19 transmission within healthcare settings. Telemedicine has become
the gold standard; however, such visits have great limitations when it comes to preventive care
such as Pap testing for cervical cancer screening.
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Background and Significance
Healthy People 2020 set a target goal of screening 93% of women for cervical cancer
according to the recommended guidelines (Nardi et al., 2016). COVID-19 threatens the
achievement of this goal as preventive healthcare is delayed and patients are reluctant to enter
healthcare facilities amid a global pandemic. Approximately 1 in 3 Americans have put off
regular health care during COVID-19 (Kaiser Health News, 2020). Suspending cancer
screenings indefinitely could lead to a surge of patients with delayed diagnoses and unfavorable
outcomes. Within the new landscape of COVID-19, striving towards the Healthy People 2020
cervical cancer screening goal requires exploration and alleviation of barriers to guidelineconsistent screening. Apart from fear of COVID-19 transmission, patient-level barriers include
inadequate knowledge of the role of cancer screening, anxiety surrounding abnormal results,
anticipation of discomfort during pelvic exam, embarrassment, perceived cost and access to
services (Nardi et al., 2016). Access and cost are further affected by busy work schedules, lack of
insurance and being unemployed (Brown et al, 2011). The leading provider-level barrier is poor
understanding of complex cervical cancer screening and management guidelines (MacLaughlin
et al., 2018). This provider-level barrier is further complicated by overseeing unfamiliar patients
of colleagues who have been redeployed or are working remotely from home during the
pandemic.
Social factors greatly influence the differential risk of contracting COVID-19 with the
most vulnerable members of society hit the hardest. Those with social disadvantage have been
found to underuse primary care and overuse hospital-based care (Pampel et al., 2010). Preventive
visits are slowly reactivating in areas where the rate of new COVID-19 cases is controlled, yet
this patient population continues to evade primary care. Wong et al (2020) conducted semi-
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structured phone interviews with patients identified through purposive sampling to understand
changes in behavior and attitudes towards healthcare since the start of the COVID-19 pandemic.
It was found that healthcare settings are perceived as infectious reservoirs and patients are not
well-informed of the current risk-mitigation efforts at such settings (Wong et al, 2020).
Low socio-economic status (SES) underlies key determinants of health including health
care, health behavior and environmental exposure. The cumulative effects of social disadvantage
across stages of the life cycle present immense challenges for an urban practice site and its
healthcare providers. Providers are responsible for managing a great level of biomedical
morbidity while confronting and navigating a complicated web of psychosocial barriers.
Minority populations are disproportionately affected by cervical cancer (Nardi et al., 2016).
“Black women account for 8.9 of 100,000 new cases and the incidence in Hispanic women is 9.4
per 100,000 cases, compared with 7.5 per 100,000 cases for white women” (Nardi et al., 2016).
Screening rates are also lower for Hispanic and African American women at 77% and 82.13%,
respectively (Nardi et al., 2016). A number of economists claim that “the lower lifetime earnings
and wealth of low-SES groups give them less reason to invest in future longevity and more
reason to focus on the present in making decisions about health behaviors” (Pampel et al., 2010).
Cervical cancer yields substantial economic burden on the population and the nation’s
health system. In 2019, an estimated 13,170 cases of invasive cervical cancer were diagnosed in
the United States with an estimated 4,250 deaths (American Cancer Society, 2019). A mixed
methods study performed by Nwankwo et al (2019) revealed that “total healthcare costs were
$4,221 higher, and an additional 0.37 workdays were missed in women with cervical cancer
compared to propensity-matched controls.” Increasing compliance with cervical cancer screening
guidelines is cost effective. According to Chesson et al (2012), approximately 52 million Pap
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tests are performed in the U.S. annually with an average cost of $103 per cervical cancer
screening. Compared to nonadherent screening practices, guideline-based cytologic screening
results in greater cancer prevention (80.9% incidence reduction; 86.7% mortality reduction) and
a lower incremental cost-effectiveness ratio (ICER) (Kim et al., 2015). In the setting of valuebased care and increased pressure to reduce healthcare costs, the cost-saving potential of proper
preventive care should not be overlooked.
Needs Assessment
A needs assessment was conducted to evaluate the strengths, weaknesses, opportunities,
and threats (SWOT), as well as, identify the barriers and facilitators for conducting the proposed
project at RiverCenter clinic. The following report is illustrated as a SWOT diagram in Appendix
A.
Barriers
Advocate Aurora Health - RiverCenter clinic manages a large volume of patients, many
of whom are of low SES with subsequent disparities in health status, morbidity and mortality.
Health disparity translates to increased medical complexity and extensive active problem lists.
Low SES is associated with less utilization of preventative and early detection services
(American Psychological Association, 2020). Low SES impacts transportation, insurance status,
ability to pay and access to medical screening (American Psychological Association, 2020).
Missed appointments and insurance gaps as well as cost of diagnostic testing and follow-up
notably reduce rates of health maintenance adherence.
RiverCenter experienced a surge in primary care provider (PCP) turn-over due to
relocation and early retirement in the setting of a global pandemic, thus increasing the risk of
patients lost to follow-up. Moreover, COVID-19 led to the expansion of telehealth or virtual care
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and the redeployment of several primary care providers. Consequently, preventive exams
requiring an in-person appointment such as cervical cancer screening have been deferred with
under-utilization of important medical services. The system lacked standardization for
communicating the need for cervical cancer screening. Lack of consistent processes impeded
effective outreach and patient education to ensure periodic care is performed based on level of
risk. RiverCenter is a busy practice, which increases the number of competing demands and
reduces the availability of providers, ancillary staff members and leadership.
Facilitators
RiverCenter encompasses a strong team-work mentality founded on a culture of
collaboration. The loss of multiple PCPs and medical assistants gave rise to an influx of new
employees who are motivated to excel and eager to learn. RiverCenter is equipped with an
experienced, efficient and diverse Registered Nurse (RN) staff. RNs triage, offer comprehensive
education and work directly with PCPs to coordinate patient care. RiverCenter has an on-site
application support information technologist, a quality improvement representative and an
organizational nursing research scientist who are well-versed in data retrieval, analysis and
management. RiverCenter maintains meaningful use of an interoperable electronic medical
record (EMR) as proposed by the Health Information Technology for Economic and Clinical
Health (HITECH) Act.
Advocate Aurora Health established a robust ambulatory reactivation plan across its
clinical sites including a Safe Care Promise, which details mandatory safety measures that have
been implemented to protect patients seeking care and team members providing care during
COVID-19. Leadership has a clear vision of success, supports professional development and is
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committed to continuous growth of the organization. Leadership prioritizes interpersonal,
transparent and consistent communication.
Problem
Cervical cancer screening has reduced the incidence of cervical cancer death by more
than 60% since its introduction in the 1950s (Rosenberg, 2019). Evidence shows that cervical
cancer mortality typically occurs among unscreened women. According to the American Cancer
Society (2019), early detection through Pap testing greatly increases the five-year survival rate
for women with cervical cancer. When cervical cancer is diagnosed as localized, the five-year
survival rate is 92% (American Cancer Society, 2019). If the cancer spreads to a different part of
the body, the five-year survival rate is reduced to 57.4% (Nardi et al., 2016). Despite the
evidence-based value of cervical cancer screening, recent updates to guidelines, and general
availability of the Pap test, guideline-adherent screening rates remain low (Rosenberg, 2019).
During COVID-19, guideline-adherent cervical cancer screening rates dropped even further
across the United States. Appointments for cervical cancer screening fell by 94% compared to
the 2017-2019 averages (Epic Health Research Network, 2020). If this trend continues, many
cancer cases will likely go undiagnosed or be diagnosed at a later stage with a poorer prognosis
(Epic Health Research Network, 2020).
Erroneous cervical cancer screening practices yield substantial consequences. As reported
by Subramaniam et al (2011), approximately 50% of invasive cervical malignancies are
diagnosed in patients that have never been screened and 10% of the remaining cervical cancer
patients have not had a Pap smear in the five years prior to diagnosis. Conversely, over-screening
yields needless healthcare expenditures, patient inconvenience as well as potential patient harm
from false-positive results and subsequent unnecessary invasive procedures (Hills et al., 2015).
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Evidence from review of the literature deemed provider training, patient education and
patient reminders to be successful methods for enhancing appropriate cervical cancer screening.
A needs assessment conducted within RiverCenter family practice clinic revealed the need to
implement such strategies to increase the rate of guideline-consistent cervical cancer screening
and follow-up during its reactivation. RiverCenter’s cervical cancer screening quality
improvement data revealed a Pap completion rate of 87% for August 2020, which was expected
to decline in the setting of delayed preventive care visits.
Purpose
The purpose of this project was to evaluate if provider training as well as patient
reminders comprising written education and risk-mitigation efforts improved guidelineconsistent cervical cancer screening rates and increased providers’ knowledge of appropriate
follow-up among eligible female patients during reopening of a large metro family practice clinic
in the wake of COVID-19.
Aims
The first aim was to meet or exceed Healthy People 2020’s target goal of screening 93%
of eligible female patients for cervical cancer by January 2021. The second aim was to improve
providers’ knowledge of guideline-consistent routine screening and follow-up for abnormal Pap
testing by 10% from baseline.
Literature Review
Review of the Evidence
A literature review was conducted in order to systematically investigate evidence of best
practice concerning interventions for improving guideline-consistent cervical cancer screening
rates and follow-up of abnormal results within the primary care setting. Review of the literature
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focused on provider training, patient education and patient reminders as means to increase
cervical cancer screening rates. Articles were searched from PubMed and CINAHL. Preceding
the search, a librarian was consulted and subsequently advised exploration of these databases.
Articles were accessed through the Himmelfarb Health Sciences Library website and search
strategies were tailored according to each individual database. Several keywords were utilized, in
various combinations, while searching the databases: papanicolaou (pap) smear, pap testing,
clinical decision support, cervical cancer, cervical cancer screening, training, education,
reminder, abnormal pap, provider adherence and guidelines. Keywords were connected with the
Boolean operators “and” and “or.” A total of 445 citations were initially identified. It is
important to note that the number of citations generated was contingent on the specific variation
of keywords used. To make the screening process less cumbersome, pertinent titles and abstracts
of articles in each database were explored further and accepted or rejected based on inclusion
and exclusion criteria. Duplicate studies were then eliminated. As a result of such editing,
approximately 15 articles were deemed relevant. The Johns Hopkins evidence appraisal tool was
used to evaluate the strength of the literature. Among the relevant articles, 5 were rejected for
inferior quality and disparate outcome measures. The articles that were identified are organized
into a table of evidence in Appendix B.
Eligible studies referenced compliance with outpatient cervical cancer screening among
biological females. More specifically, eligible studies were written in English, of USA or Canada
geographic subset, published within the last 10 years and offered access to full-text. Ineligible
studies included those that examined, exclusively, patient education interventions other than
written material and patient outreach via phone call. Studies were discarded if they focused on a
specific patient ethnicity other than ethnically diverse black women. Studies focusing on black
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women were considered applicable as RiverCenter is a city-based clinic serving a large
percentage of ethnically diverse black patients. Furthermore, it is of value to understand cervical
cancer screening rates from an ethnically diverse perspective in view of epidemiological data,
which shows that black women have high rates of cervical cancer and are more likely to die from
the disease than women of other races (Brown et al., 2011). There is a well-defined association
between inadequate screening and socioeconomic, geographic and racial disparities (Hills et al.,
2015). Female patients who have low income and educational level, those who are uninsured,
and those who have immigrated to the United States in the past 10 years account for the majority
of cervical cancer cases (National Center for Health Statistics, 2011).
Provider Knowledge, Adherence and Training
Risk for developing cervical cancer rises exponentially in women who have never
received screening, have been screened erroneously, and have delayed or no follow-up of
abnormal results (MacLaughlin et al., 2018). Studies of clinician application of the American
Cancer Society (ACS) and the American Society for Colposcopy and Cervical Pathology
(ASCCP) screening guidelines reflect low levels of understanding and compliance (Teoh et al.,
2015). A non-experimental cross-sectional survey conducted by Boone et al. (2016) determined
that distrust and confusion likely limit adherence to current evidence-based cervical cancer
screening health policy recommendations. A total of 4,909 randomly selected primary care
providers (physicians, nurse practitioners, and physician assistants) practicing in California were
mailed a study questionnaire. Of the 1,268 qualified responses received, 35.0% of all primary
care providers deemed current guidelines clinically inappropriate. Among those who
affirmatively believed current guidelines were “authoritative, reliable, and clinically
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appropriate,” only 15.3% recommended screening intervals consistent with that of current policy
guidelines (Boone et al., 2016).
Teoh et al (2015) performed a similar survey-based study, which sought to evaluate
knowledge, reported practices, and interpretations of the 2012 cervical cancer screening
guidelines among 325 health care providers in a large health maintenance organization. Of the
124 respondents, 12.1% reported they were not aware of the 2012 guideline changes and only
5.7% answered all the knowledge questions correctly. A majority of respondents reported correct
screening practices in the 21–29 year patient age group (65.8%) and in the >65 year patient age
group (74.3%). Appropriate screening intervals in the 30–65 year patient age group varied by
modality, with 89.3% correctly screening every 3 years with Pap smear alone, but only 57.4%
correctly screening every 5 years with Pap smear and human papillomavirus contesting (2015).
Across all patient age groups, the most frequently cited reasons for poor adherence were lack of
knowledge of the guidelines and patient demand for a different screening interval. As the patient
age group increased, a greater percentage of providers reported patient demand as a reason for
guideline nonadherence. As the patient age group increased, a lesser percentage of providers
reported lack of knowledge as a reason for guideline nonadherence. Hills et al. (2015) found that
individual provider educational outreach in a primary care setting contributes to a decrease in
over-screening (9.8% to 2.9%) and under-screening (52.1% to 24.7%) among patients with a
high vulnerability risk profile. White and Kenton (2013) implemented changes to the EMR and
delivered lectures to educate providers on cervical cancer screening guidelines. Following this
intervention, the total number of Pap tests done on adolescents decreased by 34% and
appropriate follow-up for abnormal results improved by 8%. However, the overall numbers of
abnormal results were very low, making it difficult to determine whether any improvements in
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management truly related to the implemented EMR changes (White & Kenton, 2013). Because
this was a retrospective review of all screened adolescents during a single calendar year rather
than following a group of specific physicians' practice patterns over a period, the study is unable
to control for changes in faculty and resident staff (White & Kenton, 2013).
Patient Education and Reminders
Some studies focused on the importance of considering a patient’s cultural beliefs and
practices when examining barriers and designing educational programs for cervical cancer
screening. Brown et al. (2011) conducted six focus groups with forty-four Haitian, African,
English-speaking Caribbean and African American women recruited from a federally qualified
health center in Essex County, New Jersey. The small, qualitative sample of primarily lowincome black women may limit the generalizability of this study; however, the following
findings are still thought-provoking. Brown et al. (2011) discovered that all ethnic groups
possessed limited knowledge and confusion about cervical cancer, risk factors, Pap testing and
human papillomavirus (HPV). Still, differences between ethnic groups in knowledge, cultural
beliefs and practices were evident. These findings suggest the need to provide culturally-based
information about the importance of screening and its role in maintaining one’s personal health.
A systematic review and metanalysis performed by Musa et al. (2017) similarly
examined the use of culturally-sensitive, linguistically-diverse education and its positive
influence on patient participation in cervical cancer screening. The use of theory-based education
increased cervical cancer screening rates by over 50% and sending invitation/reminder letters to
patients similarly increased the uptake of cervical cancer screening (Musa et al., 2017). A
systematic review of interventional studies performed by Ghare et al. (2018) concluded that
developing patient knowledge and promoting patient awareness through educational intervention
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and clear communication leads to a change in health behavior (2018). Mailed patient reminders
increased Pap testing usage by 18.8% (Ghare et al., 2018).
Other studies indicated that educating patients with written materials may be a beneficial
way to improve cervical cancer screening rates. Mazor (2014) conducted a randomized
controlled trial among 527 insured women ages 40 to 65 years in Georgia, Massachusetts,
Hawaii and Colorado with the intent to investigate the association between health literacy and
cervical cancer screening. Forty-five percent of the women in this study had at least a bachelor’s
degree and 42% reported their race as white, non-Hispanic. Spoken health literacy was
associated with screening behaviors in this population, suggesting that it has independent effects
beyond those of access to care. Women in the study had difficulty understanding spoken
recommendations about cancer screening. The authors concluded that education written in plainlanguage may be beneficial for all regardless of health literacy level. Feldmen et al. (2017)
cultivated education and communication through implementation of mailed personalized recall
letters and inclusion of educational brochures for eligible patients in a multi-site urban practice.
Cervical cancer screening rates increased from 60% pre-intervention to 71% (p<0.05) postintervention.
Several congruent themes emerged from the literature. Providers’ lack of knowledge,
misinterpretation and distrust contributes to poor adherence to current cervical cancer screening
guidelines. The complexity of the current algorithms for cervical cancer screening and
management of abnormal results warrants further provider training. Patient knowledge about
cervical cancer and its risk factors, the Pap test, and the human papillomavirus (HPV) is limited.
Personalized reminder letters for patients as well as provider and patient educational outreach are
similarly effective methods to increase cervical cancer screening rates. Of note, patients often
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have difficulty understanding spoken recommendations about cancer screening; therefore,
greater benefit is gained from written education using simple language.
Evidence-Based Practice Model
The Johns Hopkins Nursing Evidence-Based Practice Model
The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) model was selected to
guide implementation of this project. JHNEBP fosters a problem-solving approach to clinical
decision making by utilizing a three-step process called PET: practice question, evidence and
translation (Dang & Dearholt, 2017). The goal of this model is to effectively incorporate the
latest research findings and best practices into patient care (Dang & Dearholt, 2017).
Practice Question
Within a large family practice clinic that is reopening in-person preventive care visits
during COVID-19, does implementing provider training and patient reminders comprising
written education and risk-mitigation efforts increase guideline-consistent cervical cancer
screening rates and enhance providers’ understanding of appropriate follow-up among eligible
female patients ages 21-64 years?
Evidence
Literature was explored to address the derived practice question. Articles were then
reviewed and appraised using the Johns Hopkins Evidence and Quality Guide (Dang & Dearholt,
2017). Each article received strength of evidence as well as quality rating scores. Level I
constitutes the strongest level of evidence and includes randomized controlled trials or metaanalysis of randomized control trials. Level II is comprised of quasi-experimental studies. Level
III contains non-experimental and qualitative studies as well as meta-synthesis of qualitative
research. Level IV reflects the opinion of nationally recognized experts based on research
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evidence. Level V reflects the opinion of individual expert based on non-research evidence. Each
scientific evidence is also assigned a quality rating of A, B, or C. The highest quality evidence is
assigned to articles with consistent and definitive results, adequate sample size, and extensive
review of literature reflecting scientific evidence. Through review of the literature, it was
determined that sufficient higher-level evidence exists to suggest that provider training, patient
education and patient reminders are successful methods for enhancing appropriate cervical
cancer screening.
Translation
This step involved determining the viability of translating recommendations into the
specific practice setting. An action plan was created and implemented. Milestones were assigned
a scheduled time for completion and pre/post observable measures were identified. Outcomes
and positive findings were then disseminated. Please refer to the Methods and Evaluation
sections for further details.
Methods
Design
The methodology chosen for this project was based on the literature search, which
supported provider training and patient reminders comprising written education as interventions
to increase guideline-consistent cervical cancer screening rates and improve providers’
knowledge of managing abnormal cervical cytology/histology amid reopening of in-person
preventive care visits at a large metro family practice clinic. Such interventions were derived
from empirical and theoretical review of the literature. The project design is a multi-faceted,
institution-based quality improvement project.
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Setting
This quality improvement (QI) project was conducted at Aurora Health Center RiverCenter, a large family practice clinic in metro Milwaukee, Wisconsin. Advocate Aurora
Health is one of the ten largest not-for-profit integrated health systems in the United States. The
zip code (53212) in which RiverCenter clinic is located has been designated as a lower
socioeconomic status (SES) precinct with a large population density (Greer et al, 2013).
Individuals residing within this zip code are primarily African American with a median
household income of $29,653 and an unemployment rate above the state average (United States
Zip Codes, 2020). Fifty-one percent of the population is female, while 49% are male (United
States Zip Codes, 2020). The median age of the population is 28.9 years (United States Zip
Codes, 2020).
Participants
Patients
Inclusion criteria for patients who were identified to receive written education and
reminders consisted of females ages 21-64 years with a listed primary care provider at
RiverCenter clinic. Such patients must have been evaluated in-person by a provider at
RiverCenter clinic on at least 2 separate occasions. Exclusion criteria for patients included
history of total hysterectomy (unless procedure was performed as treatment for cervical precancer or cancer) or retaining a hospice code within the last 12 months. According to August
2020 clinic data there were 2,268 eligible female patients, 295 of whom were overdue for
cervical cancer screening.
Providers
Primary care providers (two female nurse practitioners, two female physician assistants,
two male physicians, and four female physicians) employed by RiverCenter clinic were invited
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to participate in a questionnaire/survey and education intervention. In order to meet study
eligibility criteria, providers must work at least a 0.5 full-time equivalent (FTE) as a primary care
provider at RiverCenter clinic.
Interventions
A methodology map of the following interventions can be found in Appendix C.
Patient Reminder Letters
The overall clinic’s monthly cervical cancer screening compliance score (%) was
calculated by the clinic’s Quality Improvement Representative (QIR). The QIR identified all
eligible females due for cervical cancer screening using an electronic query of the electronic
medical record (EMR). The cervical cancer screening score for August 2020 served as the
clinic’s baseline (pre-intervention) data. As of August 2020, 87% of 2,268 total eligible patients
at RiverCenter clinic received cervical cancer screening according to guidelines; therefore, 295
patients remained overdue for cervical cancer screening.
A patient reminder letter was created with a description of risk mitigation efforts in place
during COVID-19 and an educational brochure on cervical cancer screening approved by
Advocate Aurora Health (Appendix D). This letter was then imported into the EMR for
convenience. The QIR delivered identifiable data of patients due for cervical cancer screening
directly to two selected front desk agents, also known as Patient Service Representatives (PSR),
who then accessed the letter in the EMR and executed the reminder mailing process. Aside from
assembling and mailing patient reminder letters, the PSRs also manually tracked letters sent.
Provider Education and Questionnaire
REDCAP software was utilized to create a modified pre- and post-education provider
questionnaire based on the National Survey of Primary Care Physicians’ Cancer Screening
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Recommendations and Practices cervical cancer screening questionnaire adopted from the
National Cancer Institute in collaboration with the Agency for Healthcare Research and Quality
and Centers for Disease Control and Prevention (Appendix E). This survey applies validated
instruments to assess clinicians’ “adoption of new or rapidly-evolving screening technologies
and new screening guidelines, as well as their use of informed decision-making in discussing
cancer screening with their patients, and practice-based systems that support and/or otherwise
influence screening activities” (National Cancer Institute, 2019). The cervical cancer screening
feature of this survey was utilized to identify providers’ practice patterns as well as knowledge of
cervical cancer screening and management of abnormal Pap test results. Clinical vignettes were
adopted from the validated survey as well as from current recommendations presented by the US
Preventive Services Task Force (USPSTF) and the American Society for Colposcopy and
Cervical Pathology (ASCCP). Clinical vignettes have been shown to be a valid and cost-effective
method for assessing the quality and processes of clinical care, including cancer screening
(Peabody et al, 2004). The questionnaire was approved by Advocate Aurora Health’s
Institutional Review Board (IRB) and by the Research Subject Protection Program (RSPP).
Of note: A portion of the National Survey of Primary Care Physicians’ Cancer Screening
Recommendations and Practices is based on providers’ reports of their recommendations and
practices. Self-reported data was not validated with other data sources such as medical records or
claims. Formal permission to utilize this questionnaire was not required. Survey participation
was voluntary.
Provider education was initially intended to be delivered during an in-person staff
meeting. Due to the COVID-19 pandemic, in-person staff meetings ceased. Instead, an
education/training module was constructed and recorded using Microsoft PowerPoint. The
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provider education module was designed based on gaps in knowledge identified on providers’
pre-intervention questionnaire responses. Information conveyed in the module covered the 2018
US Preventive Services Task Force (USPSTF) cervical cancer screening guidelines as well as
management of abnormal cervical cytology and histology results as recommended by the
American Society for Colposcopy and Cervical Pathology (ASCCP). The education module was
emailed to all providers along with a link for accessing the post-education questionnaire. All
providers were emailed a reminder after 1 week to complete the questionnaire. The questionnaire
was closed 2 weeks from the time it was sent. The questionnaire took approximately 20-30
minutes to complete.
Data Collection and Analysis
Refer to Appendix F for the data collection/evaluation and analysis methods table, which
summarizes the information detailed below.
Patient Reminder Letters
The following calculation was performed electronically to obtain cervical cancer
screening compliance scores:
Number of female patients
ages 21-29 who had a
minimum of one Pap test
within the last 3 years plus
the number of female
patients age 30-64 who had
a Pap cytology in the last 3
years, or HPV or co-test in
the past 5 years

Total number of female
patients age 21-64 with
no history of
hysterectomy who had at
least 2 office visits in the
last 36 months

Cervical cancer
compliance (%)

Once received from the QIR, the aggregated monthly cervical cancer screening scores were
entered and saved into a designated Excel spread sheet. Social Sciences Statistical Package
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(SPSS) software was then used to generate a run chart to analyze cervical cancer scores over
time. Through electronic query of the EMR, the QIR was also able to track the number of
completed cervical cancer screenings among the 295 patients that received a reminder letter.
Provider Education and Questionnaire
Anonymous provider questionnaire responses were collected in a designated Excel spread
sheet. Questions 7a-7g, 8a-8c, 11-20 on the survey were marked as either incorrect or correct.
There were a total number of 20 questions that counted towards the overall score. Correct
answers were given 1 point for a total possible score of 20. The total possible score out of 20 was
calculated and expressed as a percent for each provider. Descriptive statistics (mean and standard
deviation) were analyzed through SPSS software and compared after the pre- and post-education
questionnaires were closed.
Questions 1-6 and 9-10 focused on primary care providers' attitudes, recommendations,
and practices toward use of established and emerging technologies as well as guidelines for
cervical cancer screening. While the purpose of this project did not require further analysis of
these questions, they were helpful in understanding the aforementioned factors that support
and/or influence providers’ screening activities. A Likert scale was used to determine providers’
perception of efficacy among various cervical cancer screening procedures, degree of influence
among various screening guidelines, as well as the level of agreement regarding the use of HPV
DNA testing in predicting cervical cancer and the impact of HPV vaccination on cervical cancer
screening practices. Question 21 was added to the post-education questionnaire to evaluate
providers’ perceptions of change in knowledge and practice patterns after reviewing the
education.
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Ethical Considerations
This DNP project was guided by ethical principles of autonomy, beneficence, nonmaleficence and justice.
Autonomy
Patients received comprehensible written education about cervical cancer screening in
order to foster informed decision-making. The right of the patient to decline medical care,
including cervical cancer screening, is honored by all providers. All patient data for this study
was collected as part of routine care (i.e. measuring and reporting provider performance data for
clinic use), therefore regulations for the protection of human subjects did not apply. There was
no burden placed on a patient beyond that of routine care, therefore there was no requirement for
such activities to be conducted with patient informed consent. No individually identifiable
patient data was accessible to the author for analysis.
The author does not have any supervisory relationship with the providers at RiverCenter
clinic. Providers were informed of the quality improvement interventions through an induction
session. Prior to survey engagement, providers were notified of voluntary participation. No
penalties or incentives were applied based on personal choice to respond, thus eliminating the
threat of pressure or coercion. Survey completion implied provider consent.
Beneficence and Non-maleficence
Providers and patients at RiverCenter clinic were anticipated to benefit from this project,
which aimed to improve the quality of patient care and outcomes while employing minimal risk
to its participants. An objective of this project was to increase guideline-consistent cervical
cancer screening rates, thereby reducing imposed patient risk associated with over and underscreening practices. Furthermore, the organization’s Safe Care Promise was included in the
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patient’s reminder letter in an effort to relay risk mitigation efforts in place during COVID-19.
Interventions implemented in this project were consistent with evidence-based practice.
All patients eligible to receive a reminder and educational letter were identified through
electronic query of EMR data. In order to remain in compliance with the Health Insurance
Portability and Accountability Act (HIPAA), letters did not contain any sensitive information for
individual patients. Cervical cancer screening compliance rates were collected in aggregated
form. Data collection and analysis was supervised by individuals who have been trained to carry
out QI and clinical audit projects. Access to patient data was limited to involved staff at
RiverCenter clinic. The EMR maintains an audit trail to ensure that patient data is obtained
lawfully. Survey information provided by physicians and advanced-practice clinicians remained
confidential and free of identifying data.
Justice
Inclusion and exclusion criteria for eligible patients did not comprise socioeconomic
variables such as racial group, ethnic group, marital status, financial standing or level of
education. This project endeavored to improve cervical cancer screening rates and appropriate
follow-up irrespective of a population’s socio-demographic characteristics.
Clinical Resources and Cost
RiverCenter clinic has access to an organizational nursing research scientist as well as a
quality improvement representative and an application support tech (IT) who assisted with data
retrieval and management. These resources were utilized to ensure appropriate data elements
were identified for measurement metrics.
Time represents the greatest resource and “cost” as there was limited monetary
expenditure for printing patient letters and educational brochures. Provider education was
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electronically delivered at no cost. Meeting spaces were located within the practice setting and
were widely available to use free of charge. Meetings with aforementioned team members and
providers were held during work hours, therefore no over-time pay or extension of FTE was
required.
Results
Patient Reminders Letters
All 295 patient letters were delivered from 10/01/20 - 12/01/20 with 68 of those patients
completing cervical cancer screening at the clinic. Following dissemination of patient reminder
letters encompassing education and risk-mitigation efforts practiced during the COVID-19
pandemic, the clinic’s overall cervical cancer screening score increased by 1% (Appendix G,
Figure 1).
According to the Medical College of Wisconsin Institute for Health and Equity &
Wisconsin Electronic Disease Surveillance Systems (2021), a total of 9,460 COVID-19 cases in
Milwaukee County have been identified since the first confirmed case on 03/06/20. Refer to
Appendix G (Figure 2) for an extract of the daily incidence of new cases and the average daily
incidence within the last 7 days (Wisconsin Electronic Disease Surveillance System, 2020). The
highest daily case count since the beginning of the pandemic occurred on 11/09/20 with 1,689
cases in Milwaukee County overall. At the time of data collection for all confirmed cases, 47%
were male and 53% were female. Despite the escalation in COVID-19 cases and higher rate of
infection among females, RiverCenter clinic achieved and maintained an increase in cervical
cancer screening rates.
Provider Education and Questionnaire
Pre-education Provider Questionnaire
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Eight out of ten eligible primary care providers at RiverCenter clinic completed the preintervention questionnaire, which yielded an 80% response rate. Analysis of descriptive statistics
(mean and standard deviation) revealed a mean provider score of 73.13% and a standard
deviation of 8.84. Questions regarding frequency of routine cervical cancer screening based
solely on age were answered correctly by 100% of providers. Less than 40% of the providers
answered questions 8c, 11, 14, 17, and 20 correctly. These questions examined appropriate
follow-up for women over 30 years of age with ASC-US, younger than 25 years of age with
LSIL or higher, and screening guidelines for those who are immunocompromised as well as for
women ages 65+. Refer to Appendix G (Figure 3) for the percentage of providers who answered
each question or group of questions correctly on the pre-education questionnaire.
In a typical month, the majority of providers personally order or perform cervical cancer
screening with Pap testing on 1-10 asymptomatic average-risk female patients. One hundred
percent of providers use liquid-based cytology for cervical cancer screening and order HPV
testing either for routine or follow-up testing. Providers are more inclined to refer to Gynecology
for management of patients age 30 years and older with abnormal Pap test results (ie ASC-US,
HPV positive).
Refer to Appendix G (Tables 1-3) for a summary of the following findings: Providers
considered the U.S. Preventive Services Task Force to be the most influential cervical cancer
screening guideline in their practice. Although there was variation in the perceived effectiveness
of screening with conventional and liquid-based cytology in reducing cervical cancer mortality in
average-risk women, 100% of providers agreed that HPV DNA with Pap test is very effective.
The majority of providers strongly agreed that HPV DNA testing with Pap testing is more
accurate than Pap test alone in predicting cervical cancer and that completion of the HPV
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vaccine series does not impact when cervical cancer screening is initiated. One hundred percent
of providers strongly disagreed that completing the HPV vaccine series impacts how often a
patient is screened for cervical cancer.
Post-education Provider Questionnaire
Seven out of ten providers viewed the electronic training module and completed the posteducation questionnaire. Data revealed a mean provider score of 91.43% and standard deviation
of 6.90. The post-education questionnaire score increased by 18% from baseline (Appendix G,
Figure 4). An increase was noted in the percent of providers who answered each question or
group of questions correctly following the educational intervention. There was 1 question (#12)
out of 20 questions total in which a decrease was found in the percent of providers who answered
correctly; however, this finding was attributable to a decrease in the number of providers who
completed the post-education questionnaire. Seventy-five percent, or 6 out of 8 providers,
answered question 12 correctly on the pre-education questionnaire. Approximately 71%, or 5 out
of 7 providers, answered question 12 correctly on the post-education questionnaire. Refer to
Appendix G (Figure 5) for the percentage of providers who answered each question or group of
questions correctly on the post-education questionnaire and Appendix G (Figure 6) for a
comparison to the pre-intervention questionnaire.
Six out of seven providers strongly agreed that their knowledge of cervical cancer
screening and management of abnormal Pap results improved by reviewing the educational
module. Three out of seven providers somewhat agreed and three of out seven providers strongly
agreed that their practice patterns will change as a result of reviewing the education offered. A
nonparametric Wilcoxon signed ranks test was performed through SPSS software to evaluate the
impact of training on providers’ knowledge of cervical cancer screening as well as management
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of abnormal cervical cytology and histology. Results of the Wilcoxon signed rank test revealed
that the providers’ post-education knowledge scores were significantly higher than pre-education
scores (z = 21, p = 0.02). Thus, a statistically significant improvement in providers’ knowledge
of cervical cancer screening as well as management of abnormal cervical cytology and histology
was observed following implementation of provider education.
Discussion
Amid a global pandemic where preventive health and cancer screenings have largely
been deferred, this project demonstrated a simple and cost-effective process for enhancing
provider knowledge and communicating the need for cervical cancer screening. The clinic did
not meet Healthy People’s 2020 objective of screening 93% of women for cervical cancer.
Nevertheless, the clinic did achieve a modest increase in cervical cancer screening rates
following implementation of reminder letters, which implies the value of messaging and clear
communication to encourage overdue women to be screened. Increased guideline-consistent
screening, rescreening and surveillance practices will ultimately reduce rates of cervical cancer
incidence and death. Provider training has the potential to lessen variability in interpretation and
management of screening results. Enhanced provider knowledge of current clinical guidelines
could reduce over- and under-treatment of cervical abnormalities at the cellular level, thereby
minimizing the risk of psychological stress and impairment to patients’ cervical health.
Limitations
A small sample size for the provider questionnaire limits inferences that can be made from
data analysis. Survey responses were presented in aggregate form, which excluded the ability to
compare pre- and post-questionnaire findings of the same provider. A short intervention and data
collection interval makes it difficult to conclude that patient reminder letters are not considerably
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effective. Furthermore, the socioeconomic status of patients was not identified hindering the
ability to draw associations between letter reminders and other variables in Pap smear
completion.
Recommendations and Sustainability
Given the minor increase in cervical cancer screening rates following implementation of
patient reminder letters, an alternative screening method should be explored for patients who
cannot or prefer not to have in-person appointments during the COVID-19 pandemic. Although
not yet approved by the Food and Drug Administration (FDA), home-based HPV testing is a
promising strategy for expanding accessibility of cervical cancer screening, especially in an era
of social-distancing. According to Gupta et al. (2018), “self-sampling instead of cliniciansampling has proven to be equally accurate, in particular for assays that use nucleic acid
amplification techniques.” Several studies have shown that the majority of women who tested
HPV-positive in a self-obtained sample will schedule an appointment for follow-up diagnosis
and management (Gupta et al., 2018). Self-collected HPV testing would provide an opportunity
for improved adherence to screening guidelines by eliminating some of the barriers to in-office
cervical cancer screening including time, cost, and perceived distress of gynecological
examinations.
Ongoing monitoring of cervical cancer screening rates and distribution of patient
reminder letters is needed to ensure that improvements made will be sustained over time. It
would be beneficial to conduct patient interviews about barriers and facilitators to screening in
order to inform effective messaging. Additional strategies need to be explored to address
compliance, health literacy and access-to-care barriers among a largely vulnerable patient
population. In order to sustain up to date knowledge of cervical cancer screening guidelines, the
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education module could be added to existing mandatory provider education with revisions made
as necessary.
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APPENDIX A
SWOT ANALYSIS

Internal Origin

{Attributes of the organization}














Helpful

Harmful

To achieving the objective

To achieving the objective

Strengths

Weaknesses

New providers and medical assistants who are
motivated to excel and eager to learn
Culture of teamwork and collaboration
Leadership has a clear vision of success and are
committed to continuous growth of the organization
Clinical and administrative leaders prioritize
interpersonal communication
Staff members are engaged in professional
development
Experienced, diverse Registered Nurse staff
Increased appointment availability at clinic
Large clinic increases the opportunity for in-person
meetings and educational sessions
Quality Improvement Representative and nursing
research scientist for data analysis and management
Application support information technologist for
data retrieval
Meaningful use of EMR
Safe Care Promise during COVID-19









External Origin

{Attributes of the organization}

Opportunities









Meet or exceed the targeted (top decile)
performance for Wisconsin Collaborative for
Healthcare Quality (WCHQ) and Aurora cervical
cancer screening goals.
Further reduce the morbidity and mortality
associated with cervical cancer.
Improvement of service capacities
Enhance patient/provider education
Reduce costs for inappropriate examination.
Increased interest in advancing cervical cancer
control activities.
HPV DNA-based testing has changed the landscape
of cervical cancer screening and prevention.

COVID-19 has led to the expansion of telehealth or
virtual care and the redeployment of several primary
care providers
Preventive exams requiring an in-person appointment
such a cervical cancer screening are being deferred
The system of care lacks standardization
Lack of consistent processes staff use to outreach or
educate patients to ensure periodic care based on level
of risk
Recent provider turnover increases the risk that
patients will be lost to follow-up
Busy practice lessens availability of leadership
Lack of communication strategy for cervical cancer
control

Threats





Low socio-economic status group with subsequent
large health disparities.
Relative underuse of primary care and overuse of
hospital-based care.
Cultural and financial barriers to care.
Patient population with extensive active problem lists
limits time spent addressing health maintenance
topics.
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APPENDIX B

EVIDENCE TABLE

Article
Number

Author
& Date

Evidence
Type

1

Boone, Lewis
& Karp
(2016)

Nonexperimental
cross-sectional
survey

2

Brown, D. R.
et al. (2011)

Qualitative
Study

Sample,
Sample Size,
Setting
4,909 randomly
selected primary
care providers
(physicians, nurse
practitioners, and
physician assistants)
practicing in
California

Federally qualified
health center that
provides health care
services to lowincome and
uninsured
individuals and
families in Essex
County, New Jersey.
Six focus groups
were conducted with
5 to 10 participants
each, for a total of
44 women. One
group was
conducted with
black women of
Haitian descent
(n = 8), while
another included
African immigrant
women (n = 5). Two
focus groups were
held with black
women from the
English-speaking
Caribbean (n = 12)
and 2 additional
groups were
comprised of
African American
women (n = 19).

Findings that
Help Answer
the EBP
Question

Observable
Measures

Among the primary
care
providers surveyed,
distrust and
confusion likely limit
adherence to current
evidence-based
cervical cancer
screening and health
policy
recommendations as
well as contribute to
high rates of overscreening.

Percentage of
primary care
providers (PCP)
who do not believe
current guidelines
are clinically
appropriate.

There was limited
knowledge and
confusion across
ethnic groups about
cervical cancer and
its risk factors, the
Pap test, and the
human papilloma
virus (HPV) and its
association with
cervical cancer.

Knowledge of
cervical cancer and
its risk factors, the
Pap test, and the
human papilloma
virus (HPV) and its
association with
cervical cancer.

Barriers to cervical
cancer screening
included perceived
cost, busy work
schedule, fear of the
unknown, lack of
insurance or being
unemployed.
Culturally-based
information about
the importance of
screening and
knowing that
screening helps to
maintains one's
personal health is a
facilitator of cervical
cancer screening.
Having a doctor's
recommendation was

Limitations

Evidence
Level,
Quality

Survey as a
research design
increases risk of
bias.

Level III
Quality A

Limited
generalizability
because of the
small, qualitative
sample of
primarily lowincome black
women.

Level III
Quality B

Among PCPs who
believe current
guidelines are
authoritative,
reliable and
clinically
appropriate: Rate of
screening intervals
and methodology of
testing consistent
with that of current
policy guidelines.

Cervical cancer
screening rates
(practices).
Facilitators for
cervical cancer
screening.
Barriers to cervical
cancer screening.
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of paramount
importance for
screening across all
groups.
Recommend
inclusion of women
of all ages in cervical
cancer education
because of the roles
they have in
extended families.

3

Feldman,
Davie, &
Kiran (2017)

Quality
Improvement

Multi-site urban
practice in Toronto,
Canada.
Focusing solely on
cervical cancer
screening, the
baseline screening
rates for cervical
cancer was 60%
among eligible
women ages 21-69
years.
Specific number of
women included in
the study was not
reported.

Between March 2014
and December 2016,
the cervical cancer
screening rate
increased from 60%
to 71% (p<0.05).
This increase
occurred following
implementation of
(1) personalized
recall letters for
patients signed by
their physician, (2)
inclusion of
educational
brochures with the
mailed letter, (3)
physician audit and
feedback, and (4)
improved point-ofcare reminders in the

Cancer screening
rate in accordance
with Ontario’s
cancer screening
guidelines (the
percentage of
women age 21 to
69 who had a Pap
smear within the
last 3 years).

Multiple evidencebased strategies
were implemented
concurrently, thus
limiting the ability
to assess the
contribution of
each method in
increasing cancer
screening rates.

Level V
Quality B

The effect of
diverse educational
interventions and
health behavior
change frameworks
on cervical cancer
screening behavior
of women.

Study did not
include ‘grey’
literature.

Level II
Quality A

EMR.

4

Ghare Naz et
al (2018)

Systematic
Review of
interventional
studies (RCT
and quasiexperimental)

37 articles with
15,658 female
participants in
different parts of
world were included
in the review.
33.3% of studies
were from
Americas.

Educational
interventions based
on health behavior
change theories
could help to
improve CCS
behavior of women
in different part of
the world.
Developing one’s
knowledge and
beliefs lead to the
change of health
behavior. Theorybased education lead
to increasing
knowledge and
promoting awareness
and increasing
screening rates.
An educational
intervention can help
to reduce barriers of
CCS and
subsequently can
help to increase CCS
rate.
Behavioral
interventions
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Hills, R.L.,
Kulbok, P.A.
& Clark, M.
(2015).

Quality
improvement
project, which
employed a
descriptive
comparison
study design.

1,032 eligible
female patients ages
21-64 years
receiving care at The
Fan Free Clinic in
Richmond, Virginia
and surrounding
counties.

41
example mailed or
telephone reminders
increased pap test
usage by 18.8%
Interventions:
(1) Implementation
of a clinical decision
support system, (2)
provider educational
outreach, (3) patient
reminder letters, and
(4) development of a
clinic procedure
manual.

Screened according
to evidence-based
guidelines.
Not screened.
Screened more
frequently than
recommended.

Outcomes:
Patients screened
according to
guidelines nearly
doubled.

Multifaceted
implementation
strategies were
treated as a unified
strategy thereby
precluding the
relationship of
outcomes to a
specific
intervention.

Level V
Quality A

Psychosocial
barriers to
screening were not
analyzed.

The number of
under-screened
patients was reduced
by nearly half.
There was a
threefold decrease in
patients screened
more frequently than
recommended.

6

MacLaughlin,
K.L. et al.
(2018)

Quasiexperimental
study

25,500 high-risk
women aged 18
through 65 years
receiving care at 3
separate primary
care sites affiliated
with Mayo Clinic in
Rochester,
Minnesota.

A clinical decision
support tool with
capabilities to
identify high-risk
women due for
cervical cancer
testing beyond
routine screening
intervals, with
subsequent patient
notification,
improved adherence
to guidelines and
appropriate followup.

Rate of test
completion for
high-risk patients
who were overdue
for screening or
follow-up of
abnormal Pap test,
HPV test, or
colposcopy results.

Homogeneous
demographic
characteristics of
the patient
population
(primarily white,
insured, and
educated).

Level II
Quality A

Reading and
Listening Health
literacy.

Women in this
study were all
members of
integrated
healthcare
delivery systems
thereby limiting
the ability to

Level I
Quality A/B

The average
completion rate of
recommended
follow-up testing
was significantly
higher in the
intervention group at
23.7% (61/257) than
the completion rate
at 3.3% (17/516) in
the control group
(p < 0.001).

7

Mazor, K.M.
(2014)

Randomized
Controlled Trial

527 insured women
ages 40 to 65 years
in Georgia,
Massachusetts,
Hawaii, and
Colorado

There is a
statistically
significant
association between
health literacy and

Rate of adherence
to evidence-based
recommendations
for Pap testing
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This study was
conducted within the
Cancer Research
Network (CRN), a
consortium of
research
organizations
affiliated with nonprofit integrated
healthcare delivery
systems, funded by
the National Cancer
Institute.
45 % (n=241) of the
women in this study
had at least a
bachelor’s degree.
42% (n=222) reported their race as
white, non-Hispanic.
Percent reporting
membership in other
racial or ethnic
categories were as
follows: 18 %
African–American
(n=92); 14 % Asian
or Pacific Islander
(n=74); 18 %
Hispanic (n=97);
and 7 % other or
multiple categories
(n = 36) identified.

42
cervical cancer
screening.

generalize these
findings to women
in other systems.

Women with higher
health literacy were
more likely to have
had a recent Pap test.

Generalizability
may also be
limited by the fact
that women in this
study were
volunteers. These
women may differ
in statistically
meaningful ways
from women who
did not participate.

Spoken health
literacy was
associated with
screening behaviors
in this population,
suggesting that it has
independent effects
beyond those of
access to care.
Health educators and
clinicians should be
aware that women
may have difficulty
understanding
spoken
recommendations
about cancer
screening.

8

Musa, J. et al.
(2017)

Systematic
Review &
Metanalysis

5 studies (RCT)
involving a total of
797 women who
were exposed to
cervical cancer
education and 812
women in the
comparison group.

Use of culturally
sensitive educational
materials, letters with
fact sheets on
cervical cancer and
screening, cervical
cancer screening
brochures and
invitation letters had
a significant effect
on improving patient
participation and
cervical cancer
screening rates.

The proportion of
eligible women
exposed to the
intervention or
control who
completed cervical
cancer screening
during the trial.

Failed to collect
secondary
outcome data on
the cost of cervical
cancer screening
tests, health
insurance
coverage and how
these variables
contributed to the
screening rates in
women of various
socio-economic
status, age, and
geographic
settings.

Level II
Quality A

9

Teoh, D. et
al. (2015)

Nonexperimental
cross-sectional
survey

124 providers
(physicians, nurse
practitioners,
physician assistants,
and certified nurse
midwives) in a large
health maintenance
organization in
Minnesota.

Adherence to the
2012 cervical cancer
screening guidelines
is poor due, in part,
to a lack of provider
knowledge of the
guidelines.

Knowledge of the
2012 screening
guidelines as
demonstrated by a
correct response to
6 questions that ask
the provider to
identify the
screening
recommendation
for each patient
scenario.

Small sample size
limited the ability
to conduct
subgroup analyses.

Level III
Quality A

There is no
information on
non-responders,
who may have
lower guideline
adherence rates.
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Percentage of
provider screening
practices in
accordance with
2012 guidelines
determined by
answers to 15
questions re: how
providers are
screening patients
(Pap smear alone vs
cotesting) and the
frequency at which
they are performing
each screening
modality.

Study used a selfreported survey
design to collect
data on knowledge
of the guidelines.
It is possible that
respondents were
answering the
practice questions
based on their
knowledge of the
guidelines rather
than based on a
reflection of their
true practice.

Provider views of
their practice in
relation to the
guidelines,
including how often
they adhere to the
guidelines and
reasons for not
adhering to
guidelines in each
age group.

10

White &
Kenton
(2013)

Retrospective
Review

374 females <21
years of age at
Loyola University
Medical Center

Three EMR-based
tools were
implemented to
educate providers on
cervical cancer
screening guidelines.
Following
implementation:
The total number of
Pap tests done on
adolescents
decreased by 34%.
There was a decrease
in the proportion of
co-tests ordered by
primary care
physicians.
Appropriate followup for abnormal
results improved 8%.

Providers’
compliance with
guidelines for
cervical cancer
screening in
patients less than
21 years of age.
Proportion of cotests ordered by
primary care
physicians.
Appropriate followup for abnormal
results.

The overall
numbers of
abnormal results
were very low,
making it difficult
to determine
whether any
improvements in
management truly
related to the
implemented
EMR changes.
Because this was a
retrospective
review of all
screened
adolescents during
a single calendar
year rather than
following a group
of specific
physicians'
practice patterns
over a period,
study is unable to
control for
changes in faculty
and resident staff.

Level III

CERVICAL CANCER SCREENING

44
APPENDIX C

METHODOLOGY MAP

Intervention 1:
Patient reminder letters
and monitoring of clinic’s
cervical cancer screening
(CCS) rate

Eligible female patients
are identified through
electronic query of EMR
data

Overall clinic’s CCS
compliance score (%) is
generated monthly by the
site’s Quality Improvement
Representative (QIR)

Intervention 2:
Provider training and
questionnaire

Each provider
electronically receives a
pre-education
questionnaire

QIR provides
monthly
aggregated
data to the
DNP student
for monitoring

QIR provides
identifiable patient data
to the selected Patient
Service Representatives
(PSR)

Provider responses are
collected for analysis

Provider education
module is created
based on gaps in
knowledge identified
on the preintervention
questionnaire

Providers are
reminded to complete
questionnaire after 1
week and
questionnaire is closed
after 2 weeks

Each provider
electronically receives
education module and
post-education
questionnaire

Patients due for CCS will be sent
a reminder letter comprising risk
mitigation efforts in place and an
educational brochure on cervical
cancer screening. The reminder
letter will communicate the
recommended follow-up as well
as instruction for how to schedule
an appointment or how to notify
RiverCenter clinic if follow-up
was performed elsewhere
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APPENDIX D

PATIENT REMINDER LETTER
Our records show that it is time for you to get a Pap test to protect you from cervical cancer. Please
schedule an in-clinic appointment with your primary care by choosing one of the following methods:
1. Call the clinic at 414-283-844.
2. Log into the LiveWell app and select the appointments icon from the activities page then select
schedule an appointment.
3. Go to https://myadvocateaurora.org and log in with your username and password. Select visits
then select schedule an appointment.
If you have received a Pap test at another facility within the last 3-5 years, please contact RiverCenter
clinic to find out the necessary steps to have this information forwarded to our clinic: 414-283-8444.
RiverCenter clinic is cautiously beginning to reactivate services while also managing the evolving
COVID-19 pandemic. We are dedicated to providing preventive healthcare, such as cervical cancer
screening with Pap testing. As we resume routine in-person appointments, please be assured that your
safety remains our highest priority. Enhanced procedures and protocols are in place so that you can
receive in-person care as safely and effectively as possible.
The Advocate Aurora Safe Care Promise is designed to build consumer confidence, encourage patients
to seek care they need and support our team members. Everyone will go through a COVID-19 screening
before entering our clinic. Anyone who enters our clinic wears a mask. If you do not have a mask, we will
gladly provide it. Our rearranged waiting areas and staggered appointment times reduce traffic and create
safe spaces. We have increased cleaning in all areas, including additional disinfectant for high-touch
spaces. Our visitor policy has also been updated to include one support person for adult patients who
require complex medical decision-making. For those with symptoms, we kindly ask that you stay home
and reschedule your Pap smear.
If you think you’ve been exposed to COVID-19 or are experiencing fever, cough or shortness of
breath, start with our COVID-19 Symptom Checker or call 866-443-2584.
Symptom Checker and COVID-19 Resource Center can be accessed at:
https://www.advocateaurorahealth.org/coronavirus-disease-2019/
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APPENDIX E

PROVIDER QUESTIONNAIRE
Cervical Cancer Screening Questionnaire
The following survey was adopted and modified from the National Survey of Primary Care Physicians’ Cancer
Screening Recommendations and Practices, sponsored by the National Cancer Institute (NCI) in collaboration with
the Agency for Healthcare Research and Quality (AHRQ) and Centers for Disease Control and Prevention. All
information you provide in this survey will remain confidential. Your answers will be aggregated with those of other
respondents. Participation is voluntary and there are no penalties to you for not responding.
Survey instructions: Questionnaire contains Likert scale, multiple choice and two-group categorical data. Please
select the corresponding answer(s) that best fit your current clinical practice. Assume all patients are otherwise
healthy individuals with no history of immunocompromise or increased risk unless specified in the scenario.
1. How effective do you believe the following screening procedures are in reducing cancer mortality in
average-risk women?
Very Effective

Somewhat Effective

Not Effective

Not Sure

a. Pap test (conventional cytology)
b. Pap test (liquid-based cytology)
c. HPV DNA test with Pap test
2. In your clinical practice how influential are cervical cancer screening guidelines from the following
organizations?
Very Influential Somewhat Influential Not Influential Not Familiar

a. U.S. Preventive Services Task Force
b. American Cancer Society
c. American College of Obstetricians & Gynecologists
d. American Academy of Family Physicians
e. American College of Physicians
3. During a typical month, for how many asymptomatic, average-risk female patients do you personally order
or perform cervical cancer screening with Pap testing?
o
o
o
o
o
o

0
1-10
11-20
21-30
31-40
More than 40
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4. Do you order or perform Pap testing, or work with a Nurse Practitioner (NP) or Physician’s Assistant (PA)
who orders or performs Pap testing for your female patients? Select all that apply.
o
o
o

I personally order Pap testing
I personally perform Pap testing
I work with an NP or PA who orders or performs Pap testing for my patients

5. Which cytology method do you use most often for cervical cancer screening?
o
o
o

Liquid-based – specimen suspended in liquid solution (e.g., Thin Prep or SurePath)
Conventional cytology – smear spread on glass slide and fixed
Other

6. Do you ever recommend Human Papilloma Virus (HPV) testing for your female patients? Select all that
apply.
o
o
o

Yes, I recommend HPV testing with the Pap test for routine cervical cancer screening
Yes, I recommend HPV testing as a follow up test for an abnormal Pap test
No, I do not recommend HPV testing at all

7. Assume that the following female patients present for a routine visit in your office. What would you be
most likely to recommend for Pap testing at this visit?
Answer choices for each of the following questions:
o
o
o
o
o
o
o

Pap annually
Pap every 3 years
Pap every 5 years
Pap + HPV testing annually
Pap + HPV testing every 3 years
Pap + HPV testing every 5 years
No Pap

a. 18 year-old who has never had sexual intercourse and is presenting for her 1st gynecologic visit
b. 18 year-old who had sexual intercourse for the first time 1 month ago and is presenting for her 1st
gynecologic visit
c. 18 year-old who first had sexual intercourse 3 years ago and is presenting for her 1st gynecologic visit
d. 25 year-old who has had no new sexual partners in the last 5 years and 3 consecutive negative Pap tests
e. 35 year-old who has had no new sexual partners in the last 5 years and 3 consecutive negative Pap tests
f. 35 year-old whose cervix was removed last year during hysterectomy for symptomatic fibroids. Has no
history of cervical, vaginal or vulvar dysplasia, and 3 consecutive negative Pap tests
g. Healthy 66 year-old who has had no new sexual partners in the last 5 years and 3 consecutive negative Pap
tests. Last Pap with HPV co-test was performed 3 years ago, which resulted negative
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8. How often do you recommend Pap and HPV testing for the following 35 year-old female patients? The first
number reflects the frequency of Pap testing (in years) and the second number reflects the frequency of HPV
testing (in years). “0” indicates that you would not perform the test as part of screening or follow up.
5, 0

5,5

3,0

3,3

1,0

1,1

a. HPV and Pap cytology this year were negative
b. HPV is positive and Pap cytology is negative
c. HPV is negative and Pap cytology shows ASC-US
9. Indicate your level of agreement with the following statements.
Strongly Agree Somewhat Agree Somewhat disagree Strongly Disagree
a. HPV DNA testing with Pap testing
is more accurate than Pap alone in
predicting cervical cancer
b. HPV vaccine will impact when I
start cervical cancer screening among
females who have been fully vaccinated
with the HPV vaccine
c. HPV vaccine will impact how often I
screen for cervical cancer among females
who have been fully vaccinated with the
HPV vaccine
10. There are several types of practice settings in which cervical cancer screening and follow up can be
handled. For the female patients below who are HPV positive and recently had a Pap test showing ASC-US,
please indicate what you would typically do.
Manage in my own practice

Refer to gynecology

a. Premenopausal, < 30 years old
b. Premenopausal, >+ 30 years old
c. Postmenopausal
11. A 24-year old (with no prior abnormal result) has a Pap result showing LSIL. What is the recommended
follow up?
o
o
o
o

Colposcopy
Repeat Pap in 12 months
Screening with co-testing in 3 years
Screening with Pap testing in 3 years

12. A 40 year-old (with no prior abnormal result) has normal Pap cytology with positive HPV. What is the
recommended follow up?
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Repeat co-testing in 3 years
Colposcopy
Repeat co-testing in 12 months
Screening with co-testing in 5 years

13. When should a Pap test be repeated if initial cytology returned unsatisfactory?
o
o
o
o

10-12 months
6-8 months
1-2 weeks
2-4 months

14. A 24 year-old underwent colposcopy for HSIL, which revealed absence of CIN 2/3. What is the
recommended follow up?
o
o
o
o

Repeat colposcopy and cytology every 6 months for 2 years
Repeat colposcopy and cytology every 12 months for 2 years
Repeat co-testing in 12 months
Repeat co-testing in 6 months

15. A 34 year-old (with no prior abnormal result) undergoes Pap with HPV co-testing. Her result shows ASCUS and HPV positive. What is the recommended follow up?
o
o
o
o

Colposcopy
Repeat co-testing in 3 years
Repeat co-testing in 12 months
Continue routine screening with co-testing in 5 years

16. LSIL Pap result at age 24 requires a repeat Pap test in 12 months, while LSIL Pap result at age 25
requires colposcopy.
o
o

True
False

17. Select all that apply. Women ages 65+ should stop screening when:
o
o
o

3 consecutive negative cytology tests
2 consecutive negative co-tests/HPV tests within the past 10 years
1 negative co-test/HPV test in the past 5 years regardless of prior Pap history

18. A 45 year-old underwent a complete hysterectomy for cervical dysplasia. Screening should be continued
with a vaginal swab.
o
o

True
False

19. A 20 year-old woman should undergo cervical cancer screening if this individual is sexually active and has
a history of HIV.
o
o

True
False
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20. Pap with HPV co-test was performed on a 30 year-old with history of rheumatoid arthritis on
immunosuppressant treatment. Result of cytology is normal and HPV is negative. How often should cotesting be performed on this individual?
o
o
o

Annually until 3 consecutive results are normal
Every 3 years
Every 5 years

The following question is present on the post-education questionnaire only:
21. Indicate your level of agreement with the following statements
Strongly Agree Somewhat Agree Somewhat Disagree Strongly Disagree
a. My knowledge of cervical cancer
screening and management of
abnormal Pap results improved by
reviewing the education offered
b. My practice patterns will change
as a result of reviewing the education
offered
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APPENDIX F

DATA COLLECTION/EVALUATION AND ANALYSIS METHODS TABLE
Aims/
Evaluation

Measures

Measure
Type

Data Source

Increase RiverCenter
clinic’s cervical
cancer screening
rates.

% of eligible female
patients that have
received Pap testing
with either cytology
alone or co-testing
with HPV in
accordance with
USPSTF guideline
recommendations
(the actual number of
cervical cancer pap
tests performed
divided by the total
number of eligible
patients).

Outcome

EMR chart review

Does the use of
patient reminder
letters comprising
written education and
risk-mitigation efforts
improve cervical
cancer screening
rates during
reopening of a large
metro family practice
clinic in the wake of
COVID-19?

Improve providers’
knowledge of
cervical cancer
screening guidelines
and appropriate
follow-up for
abnormal Pap testing.
Does provider
training enhance
providers’ knowledge
of appropriate
follow-up for
abnormal Pap
testing?

Recruitment
method/
Population
All eligible
female
patients as of
August 2020
who have
been
identified as
due for
cervical
cancer
screening by
the site’s QI
representative

Timing/
Frequency

Calculation/
Statistics

Goal/
Benchmark

Monthly,
spanning
from
August to
December
2020

Percentage/
Proportion

Meet or
exceed
Healthy
People
2020’s target
goal of
screening
93% of
eligible
female
patients for
cervical
cancer.
100% of
reminder
letters will be
sent to
eligible
patients (295
letters total)

% of patient reminder
letters sent to eligible
patients
Number of patients
who received a
reminder letter that
completed cervical
cancer screening with
Pap.
% of questions
answered correctly
on the modified
National Survey of
Primary Care
Physicians’ Cancer
Screening
Recommendations &
Practice
questionnaire.
Number of questions
correct divided by
total number of
questions. Percentage
will be calculated
from the following
questions: 7a-7g, 8a8c, 11-20.

Outcome

Providers’
answers on the
modified National
Survey of Primary
Care Physicians’
Cancer Screening
Recommendations
& Practice
questionnaire

Providers
were invited
to participate
in provider
training
including
completion of
pre- and posttraining
questionnaire
(voluntary).
Participants
work at least
a 0.5 fulltime
equivalent
(FTE) as a
primary care
provider at
RiverCenter
clinic: 2

Pre- and
post-test

Percentage/
Proportion
Wilcoxon
signed-rank
test will be
used to
compare two
sets of
scores that
originate
from the
same
provider
participants.

10%
improvement
in posttraining
questionnaire
score
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female nurse
practitioners,
2 female
physician
assistants, 4
female
physicians
and 2 male
physicians
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APPENDIX G

FIGURES AND TABLES
Figure 1
Aggregated Cervical Cancer Screening Score for RiverCenter Clinic (%)

87

87

87
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88

88

88
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NOVEMBER

DECEMBER

Note. The overall clinic’s cervical cancer screening rates (expressed in percentage) are shown
from July 2020 to December 2020 with a 1% increase noted in October 2020 and maintained
through December 2020
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Figure 2
COVID-19 in Milwaukee County: Daily Incidence of New Cases (Bars) and Average Daily
Incidence (Line) Within the Last 7 Days

Milwaukee County Daily Number of COVID-19 Cases

Note. At the time of data collection, a total of 9,4609 COVID-19 cases in Milwaukee County had
been identified since the first confirmed case on 03/06/20. The highest daily case count since the
beginning of the pandemic occurred on 11/09/20 with 1,689 cases in Milwaukee County overall.
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Figure 3

QUESTION NUMBER

Percent of Correct Answers on Pre-education Provider Questionnaire
20
19
18
17
16
15
14
13
12
11
8c
8a-8b
7a-7g

25
62.5
50
25
75
75
37.5
62.5
75
37.5
37.5
100
100
0

10

20

30

40

50

60

70

80

90

100

% of providers who answered question(s) correctly

Note. Questions regarding frequency of routine cervical cancer screening based solely on age
were answered correctly by 100% of providers. Less than 40% of the providers answered
questions 8c, 11, 14, 17, and 20 correctly. These questions examined appropriate follow-up for
women over 30 years of age with ASC-US, younger than 25 years of age with LSIL or higher,
and screening guidelines for those who are immunocompromised as well as for women ages 65+.
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Figure 4
Comparison of Mean Provider Score (%) on Pre- Vs. Post-education Questionnaire

Post-intervention

91

Pre-intervention

73

0

20

40

60

80

100

120

Mean Provider Questionnaire Score

Note. Eight out of ten providers completed the pre-education questionnaire with a mean score of
73.12%, standard deviation of 8.84. Seven out of ten providers completed the post-education
questionnaire with a mean score of 91.43%, standard deviation of 6.90. The post-education
questionnaire score increased by 18% from baseline.
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Figure 5

QUESTION NUMBER

Percent of Correct Answers on Post-education Provider Questionnaire
20
19
18
17
16
15
14
13
12
11
8c
8a-8b
7a-7g

57.1
100
71.4
57.1
100
85.7
85.7
100
71.4
100
100
100
100
0
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90

100

% of providers who answered question(s) correctly

Figure 6

QUESTION NUMBER

Comparing Percent of Correct Answers on Pre- Vs. Post-education Provider Questionnaire
20
19
18
17
16
15
14
13
12
11
8c
8a-8b
7a-7g

57.1

25

62.5
50
25

100
71.4

57.1
75
75

37.5
62.5

100
85.7
85.7
100

71.4 75

100
100
100
100
100
100

37.5
37.5

0

10

20

30

40

Post-intervention

50

60

70

80

90

100

Pre-intervention

Note. An increase was noted in the percent of providers who answered each question or group of
questions correctly following the educational intervention. There was 1 question (#12) out of 20
questions total in which a decrease was found in the percent of providers who answered
correctly; however, this finding was attributable to a decrease in the number of providers who
completed the post-education questionnaire.
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Table 1
Perceived Efficacy of Various Screening Procedures
How effective do you believe the following screening procedures are in reducing cancer
mortality in average-risk women?
Procedure
Pap test
(conventional
cytology)
Pap test
(liquid-based
cytology)
HPV DNA test
with Pap test

Very Effective

Somewhat
Effective

Not Effective

Not Sure

25%

50%

0%

25%

62.5%

25%

0%

12.5%

100%

0%

0%

0%

Table 2
Perceived Influence of Various Screening Guidelines
In your clinical practice how influential are cervical cancer screening guidelines from
the following organizations?
Guideline
U.S. Preventive
Services Task
Force
American Cancer
Society
American College
of Obstetricians
& Gynecologists
American
Academy of
Family Physicians
American College
of Physicians

Very Influential

Somewhat
Influential

Not Influential

Not Applicable or
Not Familiar

75%

12.5%

0%

12.5%

12.5%

50%

0%

37.5%

62.5%

25%

0%

12.5%

12.5%

75%

0%

12.5%

0%

50%

12.5%

37.5%
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Table 3
Perceived Accuracy of HPV DNA testing and the Impact of HPV Vaccination on Screening
Indicate your level of agreement with the following statements.
Guideline
HPV DNA testing
with Pap testing is
more accurate
than the Pap test
alone in
predicting
cervical cancer
The HPV vaccine
will impact when
I start cervical
cancer screening
among females
who have been
fully vaccinated
with the HPV
vaccine
The HPV vaccine
will impact how
often I screen for
cervical cancer
among females
who have been
fully vaccinated
with the HPV
vaccine

Strongly Agree

Somewhat Agree

Somewhat
Disagree

Strongly Disagree

87.5%

12.5%

0%

0%

0%

12.5%

0%

87.5%

0%

0%

0%

100%

